Siemens Healthineers has introduced its fastest, single-source CT scanner, the Somatom X.ceed.

The high-speed and high-resolution system, which is FDA 510(k) pending, is designed to simplify procedures in the most challenging clinical areas, where time and precision are critical, including cardiac and emergency imaging and CT-guided interventions.

“As the number and complexity of radiological procedures increase, demands on staff are reaching heightened levels. This continues to cause unwarranted variation in both diagnostic and interventional procedures,” said Philipp Fischer, head of computed tomography at Siemens Healthineers.
Among the features the scanner offers is myExam Companion, which provides high speed and high spatial resolution to guide users through diagnostic procedures. It enables the system to use its power and fast rotation time of 0.25 seconds per rotation to their full potential, which is key for cardiac, emergency, and spectral imaging.

It also is equipped with myNeedle Companion, the first universal solution with a harmonized user interface that allows users to plan and guide percutaneous needle procedures across modalities, including CT and angiography. Included is myNeedle Laser, a fully integrated option that projects the needle entry point and insertion angle directly on a patient’s body, even in advanced double-angulated procedures with multiple needle paths.

Somatom X.ceed comes with an 82-centimeter bore, a 120 kW X-ray tube and a user-friendly iPad tablet operation. It supports dual-energy spectral imaging and with myExam Companion, can speed up emergency imaging workflow from patient preparation to image evaluation and provide ready to read results. The feature is also predicted to help standardize results and ensure low dose levels in cardiovascular imaging procedures.

The solution is expected to be fully cleared along with myNeedle Companion by RSNA 2021. Siemens expects to receive the CE mark by the end of the summer and initially plans to focus on sales in Europe and the U.S., followed by China and Asia-Pacific.

CT Homepage